BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han W, Shi J, Cao J, Dong B, Guan W. Emerging Roles and Therapeutic Interventions of Aerobic Glycolysis in Glioma. Onco Targets Ther 2020;13:6937-55. [PMID: 32764985 DOI: 10.2147/OTT.S260376] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Wu L, Liu J, Li W. Prognostic significance of a 4-lncRNA glycolysis-related signature in oral squamous cell carcinoma. Journal of Dental Sciences 2021. [DOI: 10.1016/j.jds.2021.11.002] [Reference Citation Analysis]
2 Bingxiang X, Panxing W, Lu F, Xiuyou Y, Chao D. A Prognostic Model for Brain Glioma Patients Based on 9 Signature Glycolytic Genes. Biomed Res Int 2021;2021:6680066. [PMID: 34222480 DOI: 10.1155/2021/6680066] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kong D, Hong W, Yu M, Li Y, Zheng Y, Ying X. Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas. IJN 2022;Volume 17:1087-110. [DOI: 10.2147/ijn.s346948] [Reference Citation Analysis]
4 Wang L, Lang B, Zhou Y, Ma J, Hu K. Up-regulation of miR-663a inhibits the cancer stem cell-like properties of glioma via repressing the KDM2A-mediated TGF-β/SMAD signaling pathway. Cell Cycle 2021;20:1935-52. [PMID: 34424812 DOI: 10.1080/15384101.2021.1966962] [Reference Citation Analysis]
5 Shen L, Li Y, Li N, Zhao Y, Zhou Q, Shen L, Li Z. Integrative analysis reveals the functional implications and clinical relevance of pyroptosis in low-grade glioma. Sci Rep 2022;12:4527. [PMID: 35296768 DOI: 10.1038/s41598-022-08619-w] [Reference Citation Analysis]
6 Xu C, Yin H, Jiang X, Sun C. Silencing long noncoding RNA LINC01138 inhibits aerobic glycolysis to reduce glioma cell proliferation by regulating the microRNA‑375/SP1 axis. Mol Med Rep 2021;24:846. [PMID: 34643249 DOI: 10.3892/mmr.2021.12486] [Reference Citation Analysis]
7 Suzuki K, Kawai N, Ogawa T, Miyake K, Shinomiya A, Yamamoto Y, Nishiyama Y, Tamiya T. Hypoxia and glucose metabolism assessed by FMISO and FDG PET for predicting IDH1 mutation and 1p/19q codeletion status in newly diagnosed malignant gliomas. EJNMMI Res 2021;11:67. [PMID: 34291337 DOI: 10.1186/s13550-021-00806-6] [Reference Citation Analysis]
8 Pan Z, Bao J, Zhang L, Wei S. UBE2D3 Activates SHP-2 Ubiquitination to Promote Glycolysis and Proliferation of Glioma via Regulating STAT3 Signaling Pathway. Front Oncol 2021;11:674286. [PMID: 34195079 DOI: 10.3389/fonc.2021.674286] [Reference Citation Analysis]
9 Zhu Y, Liu Z, Lv D, Cheng X, Wang J, Liu B, Han Z, Wang Y, Liu R, Gao Y. Identification of PYGL as a key prognostic gene of glioma by integrated bioinformatics analysis. Future Oncol 2022. [PMID: 35037470 DOI: 10.2217/fon-2021-0759] [Reference Citation Analysis]
10 Li C, Guan X, Jing H, Xiao X, Jin H, Xiong J, Ai S, Wang Y, Su T, Sun G, Fu T, Wang Y, Guo S, Liang P. Circular RNA circBFAR promotes glioblastoma progression by regulating a miR-548b/FoxM1 axis. FASEB J 2022;36:e22183. [PMID: 35202487 DOI: 10.1096/fj.202101307R] [Reference Citation Analysis]